Dr. Quentin Vanhaelen
Quentin Vanhaelen, Ph.D. was recently Post-doc fellow at
Ottawa Hospital Research Institute (OHRI), Ottawa, Canada. He is now
Founder of Insilicoscreen based in Belgium which is engaged in
mathematical modeling of cellular networks.
During his Ph.D. studies, he developed a big interest in questions related to regenerative medicine. Because our ability to use stem cells is directly related to the understanding of their dynamical behavior, Quentin thinks that an engineering approach can be of great help to develop systemic approaches capable of addressing the current challenges in this field. His main area of interest is the modeling and the understanding of the dynamic of cellular networks. More precisely he focuses on the pathways playing a critical role in stem cell development.
Quentin’s papers include In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development, Design of efficient computational workflows for in silico drug repurposing, Aging as an Optimization Between Cellular Maintenance Requirements and Evolutionary Constraints, Forward and Reverse Genetics through Derivation of Haploid Mouse Embryonic Stem Cells, and Contribution to the dynamics of a deformable interface between two immiscible electromagnetically controllable fluids.
Quentin earned his Bachelor’s and Master’s in Physics (first class honor) at Université libre de Bruxelles (ULB) in 2006. He earned his DEA in Sciences at ULB in 2007. He earned his Ph.D. in Theoretical Physics (Grant FNRS–FRIA) at ULB in 2010 with the thesis On the non equilibrium thermodynamics and dynamics of a deformable interface between two electro-magnetically controllable fluids. He applied for patent Biological Glue and Method for Obtaining a Biological Glue.
Read How the bioweapon ricin kills: Scientists solve mystery through revolutionary new technology.